Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
10 min read
Auditory neuropathy spectrum disorder Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Auditory neuropathy spectrum disorder strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap.
Latest Hotspot
10 min read
Noise-induced hearing loss Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Noise-induced hearing loss strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Age-related hearing loss Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Age-related hearing loss strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Usher syndrome type 2 Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Usher syndrome type 2 strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Usher syndrome type 1 Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Usher syndrome type 1 strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Pendred syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Pendred syndrome indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
DFNB9 hearing loss Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 DFNB9 hearing loss indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Congenital stapes ankylosis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Congenital stapes ankylosis strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Vestibular migraine Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Vestibular migraine indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Superior canal dehiscence syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Superior canal dehiscence syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
Persistent postural-perceptual dizziness Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Persistent postural-perceptual dizziness strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with.
Latest Hotspot
10 min read
Otosclerosis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Otosclerosis indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.